HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report.

AbstractBACKGROUND:
Tacrolimus is an immunosuppressive drug used to prevent acute rejection following organ transplantation and to treat autoimmune disease. Tacrolimus is usually prescribed in such situation at a dose of 3.0 mg/day. Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cases; however, we encountered a rare case of Pneumocystis pneumonia induced by low-dose tacrolimus and methylprednisolone.
CASE PRESENTATION:
We herein report the case of an 82-year-old Asian Japanese female with rheumatoid arthritis and Pneumocystis pneumonia who was being treated with low-dose tacrolimus and low-dose methylprednisolone therapy. She was diagnosed with rheumatoid arthritis at 52 years of age and was administered oral low-dose methylprednisolone and salazosulfapyridine. Her condition had been stable under this treatment for 30 years. However, her arthralgia worsened three months before admission. The salazosulfapyridine was changed to tacrolimus (0.5 mg/day) by her physician, and her arthralgia almost completely disappeared. She was admitted to our hospital for Pseudomonas pneumonia, and her symptoms improved almost completely with intravenous ceftazidime therapy. However, on the 14th day of admission, she developed acute respiratory failure due to Pneumocystis pneumonia and died on the 17th day of admission in spite of adequate treatment.
CONCLUSION:
Our report highlights the importance of providing prompt prevention, diagnosis and treatment of Pneumocystis pneumonia in rheumatoid arthritis patients under tacrolimus and low-dose methylprednisolone therapy.
AuthorsMotoyasu Kato, Kazunori Tobino, Yuichi Fujimoto, Isao Kobayashi, Koji Sugano, Hitoshi Tokuda, Hiroki Ienaga, Kazuhisa Takahashi
JournalBMC research notes (BMC Res Notes) Vol. 6 Pg. 498 (Dec 01 2013) ISSN: 1756-0500 [Electronic] England
PMID24289285 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Tacrolimus
  • Methylprednisolone
Topics
  • Aged
  • Aged, 80 and over
  • Arthritis, Rheumatoid (complications)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Methylprednisolone (administration & dosage, therapeutic use)
  • Pneumonia, Pneumocystis (complications, drug therapy)
  • Tacrolimus (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: